跳至主要内容

Effect of 7 and 13-Valent Pneumococcal Conjugate Vaccines Different Number of Doses for Pneumonia Control in 2008 and 2010 Birth Cohort Children

Read  full  paper  at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53371#.VMBltSzQrzE

ABSTRACT
The 7-valent pneumococcal conjugate vaccine (PCV) was introduced in Uruguay in March 2008. In April 2010, it was replaced by PCV13. Surveillance of both vaccines was performed on hospitalized children with consolidated pneumonia. The effect of different number of vaccine doses was evaluated in 2008 and 2010 birth cohorts vaccinated with PCV7 and PCV13 respectively. The study aims to estimate the effects of PCV7 and PCV13 different number of doses on consolidated pneumonia, through the study of hospitalized children from 2008 and 2010 birth cohorts. Vaccination records of every child were available providing precise vaccination data; therefore a new approach was used to estimate PCVs effect. Incidence rate was calculated for each year of the study and for the different number of vaccine doses used each year. Exposure was calculated as person per year and rate ratio values determined the decrease of consolidated pneumonias. This decrease in percentage was estimated as the difference between the incidence with no vaccine and the incidence of every one of the doses. Incidence rate ratio revealed significant values for the three vaccine doses of PCVs for both cohorts. Upon comparing incidences, significant reduction percentages of consolidated pneumonia admissions were found. The reduction percentage of consolidated pneumonia for fully vaccinated (3 doses) patients was 69.3% and 84.6 % for PCV7 and PCV13, respectively. These results confirm that PCV7 and PCV13 are highly effective for reducing pediatric hospitalizations due to consolidated pneumonia, as reported by other national publications and demonstrated by international researchers.
 
Cite this paper
Hortal, M. , Meny, M. , Estevan, M. , Arrieta, F. and Laurani, H. (2015) Effect of 7 and 13-Valent Pneumococcal Conjugate Vaccines Different Number of Doses for Pneumonia Control in 2008 and 2010 Birth Cohort Children. World Journal of Vaccines, 5, 37-42. doi: 10.4236/wjv.2015.51005.
 
References
[1]Hortal, M., Estevan, M., Laurani, H., Iraola, I. and Meny, M., Paysandú/Salto Study Group (2012) Hospitalized Children with Pneumonia in Uruguay: Pre and Post Introduction of 7 and 13-Valent Pneumococcal Conjugated Vaccines into the National Immunization Program. Vaccine, 33, 4934-4938.
http://dx.doi.org/10.1016/j.vaccine.2012.05.054
 
[2]Hortal, M., Estevan, M., Meny, M., Iraola, I. and Laurani, H. (2014) Impact of Pneumococcal Conjugate Vaccine on the Incidence of Pneumonia in Hospitalized Children after Five Years of Its Introduction in Uruguay. PLoS One, 9, e98567. www.plosone.org
http://dx.doi.org/10.1371/journal.pone.0098567
 
[3]Ronveaux, O., Arrieta, F., Curto, S., Laurani, H. and Danovaro-Holliday, M.C. (2006) Assessment of the Quality of Immunization Data Produced by the National Individual Registration System in Uruguay, 2006. Revista Panamericana de Salud Pública, 26, 153-160.
 
[4](2001) World Health Organization Pneumonia Vaccine Trial Investigator’s Group, Standardization of Interpretation of Chest Radiographs for the Diagnosis of Pneumonia in Children, World Health Organization Geneva.
 
[5]Pita Fernández, S., Pértigas Díaz, S. and Valdés Canedo, F. (2013) Medidas de frecuencia de enfermedad. Madrid: Fisterra, Disponible en.
http://www.fisterra.com/mbe/investiga/medidas_frecuencia/med_frec2.pdf
 
[6]Prentice, R.L. (1986) A Case-Cohort Design for Epidemiologic Cohort Studies and Disease Prevention Trials. Biometrika, 73, 1-11.
http://dx.doi.org/10.1093/biomet/73.1.1
 
[7]Rothman, K.J. (1986) Modern Epidemiology. 5. Measures of Disease Frequency, 23-34. Little, Brown and Company. Boston/Toronto.
 
[8]O’Brien, K.K., Goldblatt, D. and Witney, C.G. (2014). Why Do We Need a Systematic Review of Pneumococcal Conjugate Vaccine Dosing Schedules? Pediatric Infectious Disease Journal, 33, S107-S108.
http://dx.doi.org/10.1097/INF.0000000000000075
 
[9]Pirez, M.C., Algorta, G., Sobrero, H., Varela, A., Giachetto, G. and Montano, A. (2011) Impact of Pneumococcal Universal Vaccination of Hospitalizations for Pneumonia and Meningitis in Children in Montevideo, Uruguay. Pediatric Infectious Disease Journal, 30, 669-674.
http://dx.doi.org/10.1097/INF.0b013e3182152bf1
 
[10]Picon, T., Alonso, L., Garcia Garrabot, G., Speranza, N., Casas, M., Arrieta, F., Camou, T., Rosa, R., De Oliveira, L.H., Verani, J.R. (2013) Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine against Vaccine-Type Invasive Disease among Children in Uruguay: An Evaluation Using the Existing Data. Vaccine, 315, C105-C113.
 
[11]Huebner, R.E., Mbelle, N., Forrest, B., Madore, D.V. and Klugman, K.P. (2002) Immunogenicity after One, Two or Three Doses and Impact on the Antibody Response to Coadministered Antigens of a Nonavalent Pneumococcal Conjugate Vaccine in Infants of Sweto, South Africa. Pediatric Infectious Disease Journal, 21, 1004-1007.
http://dx.doi.org/10.1097/00006454-200211000-00006
 
[12]De Wals, P., Robin, E., Fortin, E., Thibeault, R., Ouakki, M. and Douville-Frader, M. (2008) Pneumonia after Implementation of Pneumococcal Conjugate Vaccine Program in the Province of Quebec, Canada. Pediatric Infectious Disease Journal, 27, 963-968.
http://dx.doi.org/10.1097/INF.0b013e31817cf76f
 
[13]Verani, J.R., Givon-Lavi, R., Whitney, C.G., Greenberg, D. and Dagan, R. (2014) Effectiveness of Pneumococcal Conjugate Vaccine against Pneumonia in Israel. Pneumonia, S3, 278.
 
[14]Esposito, S., Lizioli, A., Lastrico, A., Begliatti, E., Rognoni, A., Tagliabue, C., Cesari, L., Carreri, V. and Principi, N. (2007) Impact on Respiratory Tract Infections If Heptavalent Pneumococcal Conjugate Vaccine Administred at 3, 5 and 11 Months of Age. Respiratory Research, 8, 12.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804265/
 
[15]Ansaldi, E., Sticchi, L., Durando, P., Begliatti, E., Rognoni, A., Tagliabue, C., Crovari, P. and Icardi, G. (2008) Decline in Pneumonia and Acute Otitis Media after the Introduction of Childhood Pneumococcal Vaccination in Liguria, Italy. Journal of International Medical Research, 26, 1255-1260.
http://dx.doi.org/10.1177/147323000803600612                                                     eww150122lx
标签：

评论

发表评论

此博客中的热门博文

A Comparison of Methods Used to Determine the Oleic/Linoleic Acid Ratio in Cultivated Peanut (Arachis hypogaea L.)

Cultivated peanut ( Arachis hypogaea L.) is an important oil and food crop. It is also a cheap source of protein, a good source of essential vitamins and minerals, and a component of many food products. The fatty acid composition of peanuts has become increasingly important with the realization that oleic acid content significantly affects the development of rancidity. And oil content of peanuts significantly affects flavor and shelf-life. Early generation screening of breeding lines for high oleic acid content greatly increases the efficiency of developing new peanut varieties. The objective of this study was to compare the accuracy of methods used to classify individual peanut seed as high oleic or not high oleic. Three hundred and seventy-four (374) seeds, spanning twenty-three (23) genotypes varying in oil composition (i.e. high oleic (H) or normal/not high oleic (NH) inclusive of all four peanut market-types (runner, Spanish, Valencia and Virginia), were individually tested ...
发表评论
阅读全文

Location Optimization of a Coal Power Plant to Balance Costs against Plant’s Emission Exposure

Fuel and its delivery cost comprise the biggest expense in coal power plant operations. Delivery of electricity from generation to consumers requires investment in power lines and transmission grids. Placing a coal power plant or multiple power plants near dense population centers can lower transmission costs. If a coalmine is nearby, transportation costs can also be reduced. However, emissions from coal plants play a key role in worsening health crises in many countries. And coal upon combustion produces CO 2 , SO 2 , NO x , CO, Metallic and Particle Matter (PM10 & PM2.5). The presence of these chemical compounds in the atmosphere in close vicinity to humans, livestock, and agriculture carries detrimental health consequences. The goal of the research was to develop a methodology to minimize the public’s exposure to harmful emissions from coal power plants while maintaining minimal operational costs related to electric distribution losses and coal logistics. The objective was...
发表评论
阅读全文

Evaluation of the Safety and Efficacy of Continuous Use of a Home-Use High-Frequency Facial Treatment Appliance

At present, many home-use beauty devices are available in the market. In particular, many products developed for facial treatment use light, e.g., a flash lamp or a light-emitting diode (LED). In this study, the safety of 4 weeks’ continuous use of NEWA TM , a high-frequency facial treatment appliance, every alternate day at home was verified, and its efficacy was evaluated in Japanese individuals with healthy skin aged 30 years or older who complained of sagging of the facial skin.  Transepidermal water loss (TEWL), melanin levels, erythema levels, sebum secretion levels, skin color changes and wrinkle improvement in the facial skin were measured before the appliance began to be used (study baseline), at 2 and 4 weeks after it had begun to be used, and at 2 weeks after completion of the 4-week treatment period (6 weeks from the study baseline). In addition, data obtained by subjective evaluation by the subjects themselves on a visual analog scale (VAS) were also analyzed. Fur...
发表评论
阅读全文